BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 21664896)

  • 1. Epigenetic regulation of CIITA expression in human T-cells.
    van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
    Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
    Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
    J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
    Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
    Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter.
    Beresford GW; Boss JM
    Nat Immunol; 2001 Jul; 2(7):652-7. PubMed ID: 11429551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility.
    Green MR; Yoon H; Boss JM
    J Immunol; 2006 Sep; 177(6):3865-73. PubMed ID: 16951349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation immediately adjacent to active histone marking does not silence transcription.
    Brinkman AB; Pennings SW; Braliou GG; Rietveld LE; Stunnenberg HG
    Nucleic Acids Res; 2007; 35(3):801-11. PubMed ID: 17202157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
    Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
    Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic landscape of histone modifications in human T cells.
    Roh TY; Cuddapah S; Cui K; Zhao K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15782-7. PubMed ID: 17043231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
    Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
    Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of epigenetic modifications of the interleukin-10 promoter on IL10 gene expression.
    Larsson L; Thorbert-Mros S; Rymo L; Berglundh T
    Eur J Oral Sci; 2012 Feb; 120(1):14-20. PubMed ID: 22288916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 19S ATPase S6a (S6'/TBP1) regulates the transcription initiation of class II transactivator.
    Truax AD; Koues OI; Mentel MK; Greer SF
    J Mol Biol; 2010 Jan; 395(2):254-69. PubMed ID: 19853614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE; Yu HN; Yoon CH; Bae YS
    Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.
    Morris AC; Beresford GW; Mooney MR; Boss JM
    Mol Cell Biol; 2002 Jul; 22(13):4781-91. PubMed ID: 12052885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.
    Tshuikina M; Nilsson K; Oberg F
    Gene; 2008 Mar; 410(2):259-67. PubMed ID: 18242011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain.
    Stadler F; Kolb G; Rubusch L; Baker SP; Jones EG; Akbarian S
    J Neurochem; 2005 Jul; 94(2):324-36. PubMed ID: 15998284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
    Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
    Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal histone modification patterns in lupus CD4+ T cells.
    Hu N; Qiu X; Luo Y; Yuan J; Li Y; Lei W; Zhang G; Zhou Y; Su Y; Lu Q
    J Rheumatol; 2008 May; 35(5):804-10. PubMed ID: 18398941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.